Peptides in Skincare: What Signal Peptides Do and What the Studies Show

Scroll a skincare feed for ten minutes and one word keeps surfacing, usually in a serif font over a glass dropper: peptides. As of March 2026, searches for peptides skincare have climbed alongside two very different conversations. One is the familiar “Botox in a bottle” claim attached to a peptide called argireline. The other is the surge of interest in injectable peptide medicines for weight management, which has quietly taught millions of people that a peptide can be a serious drug. The two ideas have blurred, and a face serum is now being asked to carry expectations it was never designed to meet.

That mix-up is worth untangling. The peptides in a moisturizer and the peptides in a prescription injection share a chemistry lesson and almost nothing else. What follows is a plain reading of how signal peptides are supposed to work, what the trials actually measured, and where these ingredients earn a spot in a routine.

What are peptides, and why does skincare care about them?

A peptide is a short chain of amino acids, the same building blocks that link together in long strings to form proteins. Think of amino acids as beads: a handful on a string is a peptide, several hundred is a protein. Collagen, the protein that gives skin its firmness, is one of those long strings. Elastin, which lets skin snap back after you smile, is another.

Skin makes and breaks down these proteins constantly. Fibroblasts, the cells in the deeper layer of skin (the dermis) that manufacture collagen, slow their output with age and with cumulative sun exposure. MedlinePlus notes that aging skin thins, loses elasticity and becomes more fragile as the connective tissue changes. That slowdown is the problem peptides skincare claims to address.

The idea is elegant. When collagen is broken down in the body, small fragments are released, and those fragments act as a message to fibroblasts: more is needed. Cosmetic chemists reasoned that applying similar fragments to the skin surface might send the same message from outside. A peptide designed for that job is called a signal peptide.

Not every peptide in a jar is a signal peptide. Some are built to carry a mineral such as copper into tissue, some aim to interfere with the muscle contractions that fold skin into expression lines, and some are intended to slow the enzymes that chew up collagen. The label rarely tells you which type you are buying, so the distinction matters more than the marketing suggests.

One more definition keeps the rest of this article honest. A cosmetic, in regulatory terms, is a product meant to cleanse or beautify without altering the body’s structure or function. Peptide serums are sold as cosmetics, which means they are not required to prove efficacy the way a medicine is before reaching a shelf.

What changed recently to put peptides skincare back in the spotlight

Three currents converged. The first is linguistic. Prescription weight-management injections that dominated health headlines through 2024 and 2025 are themselves peptides, and Cleveland Clinic’s consumer explainer on peptides now has to cover hormones, medicines and face creams in the same breath. When a word gains medical gravity, the products that borrowed it earlier inherit a credibility they did not earn through trials.

The second current is a revival of a very old claim. Acetyl hexapeptide-8, sold under the trade name argireline, has been marketed since the early 2000s as a topical that mimics the effect of botulinum toxin injections. Short-form video resurrected the phrase “Botox in a bottle” for a new audience, and the number of serums carrying the ingredient multiplied.

The third is the darker edge of the trend: so-called research peptides, injectable compounds such as BPC-157 and TB-500 sold online “for laboratory use only” and promoted for joint pain, tendon recovery and skin. These have not been approved as medicines by the FDA or comparable regulators, and they are not for sale for human use or for self-injection. Their visibility has pulled the whole category into a gray zone in the public mind.

Against that backdrop, the evidence base itself has barely moved. The benchmark for wrinkle treatment remains what Mayo Clinic and Harvard Health describe: prescription retinoids with decades of randomized data, daily broad-spectrum sunscreen, and in-office procedures for deeper lines. No peptide has entered that first tier. What has changed is attention, not proof, and that gap is exactly what a reader deserves to understand before spending on a routine.

How signal peptides are supposed to work in the skin

Picture a construction site where the crew has gone quiet. Signal peptides are meant to be the foreman walking in and pointing at the scaffolding.

In laboratory dishes, certain short sequences derived from collagen bind to receptors on fibroblasts and increase the production of collagen types I and III, along with fibronectin and other components of the extracellular matrix, the mesh of proteins that fills the space between cells and gives tissue its structure. The most studied example is palmitoyl pentapeptide-4, a five-amino-acid fragment of collagen with a fatty acid (palmitic acid) attached to help it slip through oily skin layers. It is widely sold under the name Matrixyl.

A second, less-discussed mechanism involves enzyme inhibition. Matrix metalloproteinases are enzymes that break down collagen, and their activity rises with ultraviolet exposure. Some peptides are designed to dampen these enzymes, protecting existing collagen rather than building new. Soy-derived peptides and certain tripeptides fall into this group.

The hitch is the word “supposed.” A receptor response in a culture dish does not guarantee the same response under a layer of dead skin cells, through a cream base, at the concentration a brand chose. Cell studies tell you something is biologically plausible. They cannot tell you a serum will change a face.

Why does this distinction matter for a shopper? Because plausibility is cheap and often true for dozens of ingredients that never prove themselves in people. Vitamin C, for instance, is essential to collagen synthesis in theory, yet only certain stable formulations show measurable effects on skin. Peptides sit in a similar position: a convincing story at the cellular level, with human data that is encouraging but thin. The next sections grade that data honestly.

Can a peptide even get through the skin barrier?

Skin exists to keep things out. The outermost layer, the stratum corneum, is a stack of flattened dead cells sealed with lipids, often compared to bricks and mortar. Molecules that cross it reliably tend to be small (under roughly 500 daltons, a unit of molecular weight) and somewhat oil-soluble. Water-loving molecules and large ones mostly stay on the surface.

Peptides fail that test on paper. Even a short five-amino-acid chain weighs in the neighborhood of 500 to 800 daltons, and amino acids carry electrical charges that make them water-friendly. Larger peptides and full proteins such as collagen itself have essentially no chance of reaching the dermis intact, which is why collagen creams are best understood as moisturizers.

Chemists address this in a few ways. Attaching a fatty acid tail, as in palmitoyl pentapeptide-4, makes the molecule more lipid-friendly. Formulating in a vehicle with penetration enhancers helps. Using very low concentrations, as most products do, also reflects the fact that only a fraction is expected to arrive.

Whether enough arrives to matter is an open question, and it is the right question to ask. Some researchers argue that signal peptides may not need to reach fibroblasts at all; if they interact with cells in the epidermis, the living layer just below the stratum corneum, those cells could relay messages downward. Others point out that peptides are also food for enzymes in the skin that chop them into single amino acids before they do anything.

The practical consequence is that formulation matters as much as the ingredient name. Two serums listing the same peptide can deliver very different amounts. Since brands rarely publish penetration data, the only trustworthy proxy is whether a product’s specific formula, not its headline ingredient, has been tested on people.

What the evidence actually says, graded honestly

Medical evidence comes in tiers. At the top sit large randomized controlled trials, where people are assigned by chance to a treatment or a comparison and neither group knows which they received. Below that come small randomized or split-face studies, then observational studies that follow users without a control group, then laboratory work, then expert opinion. Here is where peptides land.

Palmitoyl pentapeptide-4 has the strongest footing. Several small randomized, double-blind studies, typically 20 to 90 participants over 8 to 12 weeks, reported measurable reductions in wrinkle depth and roughness around the eyes compared with the same cream without the peptide. The effect sizes were modest and most studies were funded or run by ingredient manufacturers, which does not invalidate them but lowers confidence.

Copper tripeptide (GHK-Cu) has a longer research history in wound healing, including animal and small human studies, plus a few small facial trials in the early 2000s suggesting improved firmness and reduced fine lines. Much of this is older, open-label or sponsor-driven.

Acetyl hexapeptide-8 has a handful of small trials, some randomized, showing small changes in wrinkle measurements; the headline figures often quoted online come from one short manufacturer study with no long-term follow-up.

For most other peptides on labels, the published evidence is laboratory work or unpublished company data. Grade: low.

The comparison is sobering. Harvard Health’s review of retinoids rests on decades of randomized trials showing reduced fine lines, improved texture and increased dermal collagen on biopsy. Daily sunscreen, as the NHS and CDC emphasize, is the single best-supported way to slow visible skin aging because it prevents the ultraviolet damage that drives it. Peptides are promising supporting players with low-to-moderate evidence. Saying so plainly is the most useful thing this article can do.

Copper peptides benefits: what GHK-Cu does and does not show

Copper peptides are the ingredient most likely to be described in near-mystical terms, so they deserve a sober look. GHK-Cu is a tripeptide (three amino acids: glycine, histidine, lysine) bound to a copper ion. It occurs naturally in human plasma, and its concentration declines with age, which is the origin of the “replace what you have lost” marketing story.

The research interest began in wound care. Copper is a cofactor for lysyl oxidase, an enzyme that cross-links collagen and elastin into stable fibers, and GHK-Cu appears to attract immune and repair cells to injured tissue in animal models. Small human studies in the 1990s and 2000s examined it in healing wounds and in post-procedure skin.

For intact facial skin, the trials are few and small. A couple of controlled studies reported improved skin density and reduced fine lines after 12 weeks compared with placebo or with a vitamin C cream, but participant numbers were in the dozens and the work was largely industry-supported. There is no large independent trial, and no long-term safety data in the sense a medicine would require, although topical use appears well tolerated.

Two practical cautions follow from the chemistry. Copper peptides are sensitive to pH and can be destabilized by strong acids or by high-dose vitamin C in the same application; many formulators recommend applying them at a different time of day from exfoliating acids. And a small subset of users report tingling or redness, so a patch test is reasonable.

Where does that leave the shopper? Copper peptides are a defensible choice for someone who tolerates them and wants a gentle, non-irritating ingredient alongside sunscreen and a retinoid. They are not a substitute for either, and claims of “skin remodeling” outrun what the human studies measured.

Is argireline really "Botox in a bottle"?

The phrase is doing heavy lifting. Botulinum toxin injections work by blocking the release of acetylcholine, the chemical messenger that tells a muscle to contract, at the junction between nerve and muscle. With the muscle quieter, the overlying skin stops folding, and dynamic wrinkles soften over days.

Acetyl hexapeptide-8 was designed to interfere with a different piece of that same machinery, the SNARE complex, a set of proteins that lets nerve endings release their chemical cargo. In cell experiments it reduces the release of acetylcholine. That is the scientific thread the marketing pulls on.

The thread is thin at the point where it matters. Botulinum toxin is injected directly into muscle. A topical peptide must cross the stratum corneum, the epidermis and the dermis, then reach nerve endings beneath the skin, all while surviving enzymes that break peptides apart. Most researchers consider meaningful muscle relaxation from a cream implausible at cosmetic concentrations.

What the human studies actually report is a small reduction in wrinkle depth measured by skin surface imaging after about four weeks, in trials involving a few dozen volunteers. Those changes could reflect mild hydration and surface smoothing, effects most moisturizers share, rather than neuromuscular action. No trial has shown reduced muscle movement on electromyography in a way comparable to injection, and no head-to-head comparison with botulinum toxin exists.

The honest summary: argireline is a well-tolerated peptide with low-grade evidence for modest surface smoothing. It does not replicate the mechanism or the visible results of an injected neuromodulator, and a product that implies otherwise is making a claim the studies do not support. Anyone weighing injectable treatments should discuss them with a board-certified dermatologist or plastic surgeon rather than expecting a serum to serve as a trial run.

Peptides vs retinol and other actives: a side-by-side look

Ingredient debates online tend to treat skincare as a tournament with one winner. Skin does not work that way; most dermatologists layer a few well-evidenced actives and ignore the rest. The table below summarizes how the common contenders compare on mechanism and evidence strength.

Ingredient	Main proposed action	Human evidence for aging skin	Typical tolerability
Retinoids (prescription tretinoin, OTC retinol)	Bind nuclear receptors, increase collagen, speed cell turnover	Strong: decades of randomized trials with biopsy confirmation	Irritation, dryness and sun sensitivity, usually easing over weeks
Broad-spectrum sunscreen	Blocks UV damage that degrades collagen	Strong: randomized trial showing less visible aging with daily use	Excellent
Niacinamide (vitamin B3)	Supports barrier lipids, reduces pigment transfer, calms inflammation	Moderate: several randomized trials for texture, tone and barrier	Excellent; rare flushing
Vitamin C (stable forms)	Antioxidant; cofactor in collagen synthesis	Moderate: small randomized trials, formulation-dependent	Can sting at low pH
Signal peptides (e.g., palmitoyl pentapeptide-4)	Signal fibroblasts to make collagen	Low to moderate: small, short, mostly sponsor-funded trials	Excellent
Copper peptides (GHK-Cu)	Collagen cross-linking cofactor, repair signaling	Low: older small studies, wound-healing background	Good; occasional tingling
Neurotransmitter-inhibiting peptides (argireline)	Intended to reduce nerve signaling to muscle	Low: small trials, surface smoothing only	Excellent

Read across the rows and a pattern emerges. The two interventions with the strongest proof, sunscreen and retinoids, are also the least glamorous. Peptides earn their place mainly through tolerability: they are a rational option for skin that cannot handle a retinoid yet, or as a daytime partner to a nighttime retinoid. Choosing a peptide instead of a retinoid trades evidence for comfort, and that trade should be made knowingly.

Is peptide better than niacinamide?

This question appears in searches constantly, and the answer depends on what you want fixed. The two ingredients do different jobs, so “better” has to be anchored to a goal.

Niacinamide is a form of vitamin B3. In skin it increases production of ceramides, the lipids that seal the barrier, and it slows the transfer of pigment from melanocytes to surrounding skin cells, which is why it helps uneven tone. Several randomized, vehicle-controlled trials over 8 to 12 weeks have shown improvements in blotchiness, yellowing, fine lines and barrier function, with excellent tolerability. By cosmetic-ingredient standards, that is a respectable evidence base, a notch above peptides.

Peptides, as the earlier sections describe, aim at collagen signaling and surface smoothing. Their trials are smaller and shorter.

So the comparison shakes out like this. For redness, enlarged-looking pores, uneven tone or a compromised barrier, niacinamide has more support. For a gentle, well-tolerated ingredient targeting fine lines in someone who cannot use a retinoid, a peptide is a reasonable choice, with the caveat that the gains are likely to be modest. For deeper wrinkles, neither compares to a retinoid or professional treatment.

There is no need to choose between them. The two are compatible, do not destabilize each other, and are frequently combined in the same product. A sensible routine for sensitive skin might pair niacinamide in the morning under sunscreen with a peptide serum at night, adding a retinoid later as tolerance allows.

The question hiding behind this one is whether a more expensive-sounding ingredient must be the more effective one. It is not. Niacinamide is inexpensive to manufacture and heavily studied; many peptides are costly to synthesize and lightly studied. Evidence and sophistication do not travel together.

How to read a peptide serum for face label like a chemist

Ingredient lists are ranked by concentration from highest to lowest, with an exception: anything below 1 percent can be listed in any order. Peptides are almost always used below 1 percent, often far below, so their position near the bottom of a list tells you little. A serum can legitimately headline a peptide that is present in trace amounts.

Names help more than positions. Palmitoyl pentapeptide-4 (Matrixyl), palmitoyl tripeptide-1, palmitoyl tetrapeptide-7 (the latter two are often sold together as Matrixyl 3000), copper tripeptide-1 and acetyl hexapeptide-8 are the ingredients with any published human data. A long, unfamiliar peptide name is not a red flag, but it usually signals that the evidence is a laboratory study at best.

Look at the vehicle. Peptides are typically water-soluble and work best in serums or light lotions; a peptide listed in a cleanser is rinsed away before it can do anything. A product in an opaque, airless pump protects the peptide from light and oxidation better than a clear dropper bottle.

Check pH compatibility if you layer actives. Copper peptides can be destabilized by low-pH products such as glycolic acid or L-ascorbic acid vitamin C. Most other peptides are stable across the pH range of ordinary skincare.

Be skeptical of percentages. “10 percent peptide complex” usually describes a pre-made solution in which the active peptide is a small fraction; the number refers to the solution, not the peptide.

Finally, treat before-and-after photos as advertising, not data. Lighting, hydration and expression change wrinkle appearance within minutes. The useful question for any peptide serum for face is whether the brand has tested that specific formula on people under controlled conditions and published the results. Few have.

Who is most likely to benefit from peptides skincare, and how to use it realistically

Not every face needs a peptide, and the people who stand to gain most are often those for whom the heavy hitters are off the table.

Sensitive, reactive or rosacea-prone skin is the clearest case. Retinoids can be too irritating at first, and vitamin C at low pH can sting. Peptides are among the gentlest actives available and can offer something to apply while a retinoid is introduced slowly. People with eczema or very dry skin may similarly appreciate a peptide-containing moisturizer that does not disrupt the barrier.

Pregnancy and breastfeeding are another situation where many people set aside retinoids on their clinician’s advice. Topical peptides have no known concern in this setting, though the absence of data is not the same as proof of safety; this is a conversation to have with an obstetric provider rather than a comment section.

Skin that is already on a prescription retinoid and daily sunscreen can add a peptide as a supporting step, with modest expectations. In practice, a peptide serum applied in the morning under sunscreen, with the retinoid at night, is a common and compatible arrangement.

Realistic expectations matter more than the product. In the trials that showed benefit, changes appeared after 8 to 12 weeks of twice-daily use and were measured with instruments; a mirror may show softer texture and better hydration rather than dramatically fewer lines. Deep folds, sagging and sun damage are not within reach of any topical peptide.

One habit does more for collagen than any serum: wearing broad-spectrum sunscreen every day, as the NHS and the CDC advise, because ultraviolet light is the main driver of the collagen breakdown peptides are trying to counter. A peptide without sunscreen is bailing a boat with the drain open.

Common myths about peptides for skin, corrected

Viral claims travel faster than citations. Here are the ones most worth correcting.

“Peptides are a natural alternative to Botox.” Topical neurotransmitter-inhibiting peptides have shown only small surface-smoothing effects in small trials. They do not relax muscle the way an injected neuromodulator does, and no study has compared them head to head.

“Collagen in a cream rebuilds your collagen.” Collagen is a large protein that cannot cross the skin barrier. Collagen creams moisturize. Signal peptides are the only topical approach with a plausible path to influencing collagen production, and even that evidence is modest.

“More peptides means better results.” There is no dose-response data showing that stacking six peptides beats one studied peptide at a tested concentration. Complexity on a label often reflects marketing, not pharmacology.

“Copper peptides remodel the skin.” The remodeling language comes from wound-healing research in animals and small post-procedure studies. On intact facial skin, the human trials are small and old, and they measured modest changes in firmness and fine lines.

“If it’s a peptide, it works like the weight-loss injections.” Prescription peptide medicines are large, specific molecules delivered by injection and tested in large randomized trials. Cosmetic peptides share the chemical category and nothing else: different molecules, different route, different standard of proof.

“Peptides can replace retinoids for people who don’t want irritation.” They can substitute during a period when a retinoid is not tolerated, but the evidence for retinoids is in a different tier. Choosing a peptide alone means accepting smaller, less certain gains.

“Results show in a week.” Anything visible that quickly is hydration. The trials that found benefit ran 8 to 12 weeks.

Will peptides help with SI joint pain? The injectable peptide question

This question lands in a skincare article because the word “peptide” has leaked across categories. People searching for relief from sacroiliac (SI) joint pain, the ache where the base of the spine meets the pelvis, are finding online forums promoting injectable compounds such as BPC-157, TB-500 and various growth-hormone-releasing peptides for joint and tendon recovery.

The regulatory status needs stating plainly. These compounds have not been approved as medicines for human use by the FDA or by equivalent agencies. They are sold online labeled “for research use only” or “not for human consumption,” which is a legal disclaimer, not a safety certification. They are not for sale for self-injection and should not be used that way. The purity, sterility and actual contents of such vials are unverified, and injecting an unregulated product carries risks of infection, contamination and unknown systemic effects.

On evidence, the picture is thin. BPC-157 has been studied mainly in rodents, where it appeared to speed tendon and ligament healing. Published human trials are essentially absent. For SI joint pain specifically, there are no controlled human studies of any injectable research peptide. The claims circulating online rest on animal data and anecdote.

SI joint pain itself has well-established, evidence-based approaches that a clinician can tailor: physical therapy focused on core and pelvic stability, activity modification, anti-inflammatory medicines when appropriate, and in persistent cases image-guided corticosteroid injections or other procedures. Those decisions belong to a treating physician, physiatrist or orthopedic specialist who can examine the joint and rule out other causes.

Topical skincare peptides, for the record, have no connection to joint pain whatsoever. If a product implies otherwise, that is a signal to step away from the seller, not toward the cart.

When to see a doctor about skin changes or peptide products

Most people using peptide serums will never need medical input; the ingredients are mild and the stakes are cosmetic. A few situations are different.

See a dermatologist or your primary care clinician if a product causes persistent redness, swelling, burning, hives or blistering, especially if symptoms spread beyond where it was applied. These can signal contact dermatitis or an allergic reaction and may warrant patch testing to identify the culprit.

Seek care promptly for any new or changing spot on the skin: a mole that has grown, changed color, developed an irregular border or started bleeding or itching. No skincare ingredient treats skin cancer, and the CDC and NHS both stress that early evaluation of suspicious lesions matters. Do not wait to see whether a serum helps.

Book an appointment if you are considering injectable treatments, whether neuromodulators, fillers or anything marketed as a peptide injection. Only a licensed clinician should assess suitability, and no injectable product bought online for self-use is safe or appropriate.

Talk to your prescribing clinician before adding peptides if you are on a prescription retinoid, a topical steroid, acne medication or any treatment for a skin condition such as rosacea, psoriasis or eczema. Peptides rarely interact, but your clinician may want to adjust the order or timing of application. Never stop or change a prescribed treatment on the strength of an over-the-counter alternative.

Red-flag signs that need urgent care, not a routine visit, include facial swelling involving the lips or eyes, difficulty breathing after applying a product, or signs of infection such as spreading warmth, pus or fever after any injection, including those obtained outside a clinic.

Every treatment decision, cosmetic or medical, belongs with the clinician who can see your skin in person and knows your history.

Frequently asked questions

What are peptides in skincare?

Peptides are short chains of amino acids, the building blocks of proteins such as collagen. In skincare they are added to serums and creams to signal skin cells to make more collagen, to carry minerals like copper, or to soften expression lines. They are sold as cosmetics, not medicines, and the human evidence for their effects is modest and short term.

What do peptides do for skin, realistically?

In small trials, signal peptides such as palmitoyl pentapeptide-4 produced measurable reductions in fine-line depth and roughness after 8 to 12 weeks, alongside better hydration. Deep wrinkles, sagging and sun damage were not changed. Expect softer texture and a well-tolerated step in a routine rather than a dramatic transformation.

Is peptide better than niacinamide?

Neither is better overall; they do different jobs. Niacinamide has stronger randomized-trial support for uneven tone, redness and barrier repair. Peptides target fine lines and are extremely gentle. For most skin, using both is more sensible than choosing one, and neither replaces a retinoid for wrinkles.

Peptides vs retinol: which should I use?

Retinol and prescription retinoids have far stronger evidence, including biopsy-confirmed collagen increases in randomized trials. Peptides are a gentler option for skin that cannot tolerate a retinoid yet. Many people use a peptide in the morning and a retinoid at night; ask a dermatologist if you are unsure how to combine them.

What are copper peptides benefits and are there downsides?

Copper tripeptide (GHK-Cu) has a background in wound-healing research and a few small, older facial studies suggesting improved firmness and fine lines. The evidence is low grade. It is usually well tolerated, though some people notice tingling, and it can be destabilized by strong acids or low-pH vitamin C applied at the same time.

Is argireline really Botox in a bottle?

No. Argireline (acetyl hexapeptide-8) interferes with nerve signaling in laboratory cells, but it must cross several skin layers to reach nerve endings, which is considered unlikely at cosmetic concentrations. Small trials show only surface smoothing, and no study has compared it with injected botulinum toxin.

How long does a peptide serum for face take to work?

Studies that found benefit ran 8 to 12 weeks with twice-daily use before measuring changes with imaging instruments. Any smoothing visible within days is hydration from the base formula, not a collagen effect. Give a product at least two to three months before judging it, and keep sunscreen in the routine throughout.

Will peptides help with SI joint pain?

There is no human evidence that any peptide treats sacroiliac joint pain. Injectable compounds promoted online, such as BPC-157, have been studied mainly in animals, are not approved for human use and are not for sale or self-injection. Topical skincare peptides have no connection to joints. See a clinician for evidence-based care of SI joint pain.

Can I use peptides with vitamin C or exfoliating acids?

Most signal peptides are stable alongside other actives. Copper peptides are the exception: low-pH products such as L-ascorbic acid vitamin C or glycolic acid can destabilize them, so many formulators suggest applying them at a different time of day. When in doubt, use the acid in the morning and the peptide at night.

Are peptides safe during pregnancy?

Topical peptides have no known safety concern in pregnancy, which is why some people use them while setting aside retinoids. That said, specific safety studies in pregnancy do not exist, so the absence of data is not proof. Discuss any skincare active with your obstetric provider rather than assuming.

References

• MedlinePlus: Aging changes in skin
• NHS: Sunscreen and sun safety
• CDC: Sun Safety

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.